Q9NYF8 (BCLF1_HUMAN) Reviewed, UniProtKB/Swiss-Prot
Last modified
April 3, 2013.
Version 113.
History...
Names·Attributes·General annotation·Ontologies·Interactions·Alt products·Sequence annotation·Sequences·References·Cross-refs·Entry info·DocumentsCustomize order
Names·Attributes·General annotation·Ontologies·Interactions·Alt products·Sequence annotation·Sequences·References·Cross-refs·Entry info·DocumentsCustomize orderNames and origin
| Protein names | Recommended name: Bcl-2-associated transcription factor 1 Short name=Btf | ||||
| Gene names |
| ||||
| Organism | Homo sapiens (Human) [Reference proteome] | ||||
| Taxonomic identifier | 9606 [NCBI] | ||||
| Taxonomic lineage | Eukaryota › Metazoa › Chordata › Craniata › Vertebrata › Euteleostomi › Mammalia › Eutheria › Euarchontoglires › Primates › Haplorrhini › Catarrhini › Hominidae › Homo![]() |
Protein attributes
| Sequence length | 920 AA. |
| Sequence status | Complete. |
| Protein existence | Evidence at protein level |
General annotation (Comments)
| Function | Death-promoting transcriptional repressor. May be involved in cyclin-D1/CCND1 mRNA stability through the SNARP complex which associates with both the 3'end of the CCND1 gene and its mRNA. Ref.11 |
| Subunit structure | Interacts with Bcl-2 related proteins, EMD, with the adenovirus E1B 19 kDa protein and with DNA. Component of the SNARP complex which consists at least of SNIP1, SNW1, THRAP3, BCLAF1 and PNN. Ref.7 Ref.11 |
| Subcellular location | |
| Tissue specificity | Ubiquitous. |
| Sequence caution | The sequence AAH47687.1 differs from that shown. Reason: Contaminating sequence. Potential poly-A sequence. The sequence AAH47887.1 differs from that shown. Reason: Contaminating sequence. Potential poly-A sequence. The sequence AAH56894.1 differs from that shown. Reason: Contaminating sequence. Potential poly-A sequence. The sequence AAH63846.1 differs from that shown. Reason: Contaminating sequence. Potential poly-A sequence. The sequence BAA11481.2 differs from that shown. Reason: Erroneous initiation. |
Ontologies
Binary interactions
With | Entry | #Exp. | IntAct | Notes |
|---|---|---|---|---|
| EMD | P50402 | 3 | EBI-437804,EBI-489887 |
Alternative products
| This entry describes 4 isoforms produced by alternative splicing. [Align] [Select] | ||||||
| Isoform 1 (identifier: Q9NYF8-1) This isoform has been chosen as the 'canonical' sequence. All positional information in this entry refers to it. This is also the sequence that appears in the downloadable versions of the entry. | ||||||
| Isoform 2 (identifier: Q9NYF8-2) Also known as: Btf-l; The sequence of this isoform differs from the canonical sequence as follows: 35-36: Missing. | ||||||
| Isoform 3 (identifier: Q9NYF8-3) Also known as: Btf-s; BP-1; The sequence of this isoform differs from the canonical sequence as follows: 35-36: Missing. 800-848: Missing. | ||||||
| Isoform 4 (identifier: Q9NYF8-4) The sequence of this isoform differs from the canonical sequence as follows: 339-511: Missing. |
Sequence annotation (Features)
| Feature key | Position(s) | Length | Description | Graphical view | Feature identifier | ||||
Molecule processing | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Chain | 1 – 920 | 920 | Bcl-2-associated transcription factor 1 | PRO_0000064888 | |||||
Regions | |||||||||
| Compositional bias | 141 – 148 | 8 | Poly-Ser | ||||||
| Compositional bias | 749 – 763 | 15 | Poly-Ser | ||||||
Amino acid modifications | |||||||||
| Modified residue | 102 | 1 | Phosphoserine Ref.17 | ||||||
| Modified residue | 104 | 1 | Phosphoserine Ref.17 | ||||||
| Modified residue | 119 | 1 | Phosphoserine By similarity | ||||||
| Modified residue | 122 | 1 | Phosphoserine By similarity | ||||||
| Modified residue | 125 | 1 | Phosphoserine By similarity | ||||||
| Modified residue | 152 | 1 | N6-acetyllysine Ref.16 | ||||||
| Modified residue | 177 | 1 | Phosphoserine Ref.6 Ref.8 Ref.14 Ref.15 Ref.17 Ref.19 | ||||||
| Modified residue | 181 | 1 | Phosphoserine Ref.13 | ||||||
| Modified residue | 196 | 1 | Phosphoserine Ref.17 Ref.19 | ||||||
| Modified residue | 198 | 1 | Phosphoserine Ref.17 Ref.19 | ||||||
| Modified residue | 222 | 1 | Phosphoserine Ref.13 Ref.15 Ref.17 Ref.19 | ||||||
| Modified residue | 264 | 1 | Phosphoserine Ref.13 | ||||||
| Modified residue | 268 | 1 | Phosphoserine Ref.6 Ref.13 Ref.17 Ref.19 | ||||||
| Modified residue | 284 | 1 | Phosphotyrosine Ref.13 | ||||||
| Modified residue | 285 | 1 | Phosphoserine Ref.19 | ||||||
| Modified residue | 287 | 1 | Phosphoserine By similarity | ||||||
| Modified residue | 290 | 1 | Phosphoserine Ref.6 Ref.13 Ref.15 Ref.17 Ref.19 | ||||||
| Modified residue | 297 | 1 | Phosphoserine Ref.17 | ||||||
| Modified residue | 335 | 1 | N6-acetyllysine Ref.16 | ||||||
| Modified residue | 341 | 1 | Phosphothreonine Ref.13 | ||||||
| Modified residue | 385 | 1 | Phosphoserine Ref.13 Ref.15 Ref.17 Ref.19 | ||||||
| Modified residue | 389 | 1 | Phosphoserine Ref.8 Ref.13 | ||||||
| Modified residue | 397 | 1 | Phosphoserine Ref.8 Ref.9 Ref.12 Ref.13 Ref.14 Ref.15 Ref.17 Ref.19 | ||||||
| Modified residue | 402 | 1 | Phosphothreonine Ref.8 Ref.13 Ref.15 Ref.17 | ||||||
| Modified residue | 437 | 1 | N6-acetyllysine Ref.16 | ||||||
| Modified residue | 472 | 1 | Phosphoserine Ref.17 | ||||||
| Modified residue | 494 | 1 | Phosphothreonine Ref.19 | ||||||
| Modified residue | 496 | 1 | Phosphoserine Ref.17 Ref.19 | ||||||
| Modified residue | 502 | 1 | Phosphoserine Ref.17 | ||||||
| Modified residue | 512 | 1 | Phosphoserine Ref.6 Ref.13 Ref.15 Ref.17 Ref.19 | ||||||
| Modified residue | 531 | 1 | Phosphoserine Ref.6 Ref.8 Ref.13 Ref.17 Ref.19 | ||||||
| Modified residue | 566 | 1 | Phosphothreonine Ref.17 | ||||||
| Modified residue | 578 | 1 | Phosphoserine Ref.13 Ref.17 | ||||||
| Modified residue | 648 | 1 | Phosphoserine Ref.8 | ||||||
| Modified residue | 658 | 1 | Phosphoserine Ref.6 Ref.13 Ref.17 Ref.19 | ||||||
| Modified residue | 660 | 1 | Phosphoserine Ref.19 | ||||||
| Modified residue | 690 | 1 | Phosphoserine Ref.17 | ||||||
| Modified residue | 760 | 1 | Phosphoserine Ref.19 | ||||||
| Modified residue | 840 | 1 | Phosphothreonine By similarity | ||||||
Natural variations | |||||||||
| Alternative sequence | 35 – 36 | 2 | Missing in isoform 2 and isoform 3. | VSP_010369 | |||||
| Alternative sequence | 339 – 511 | 173 | Missing in isoform 4. | VSP_010371 | |||||
| Alternative sequence | 800 – 848 | 49 | Missing in isoform 3. | VSP_010370 | |||||
| Natural variant | 66 | 1 | G → A. Corresponds to variant rs9942517 [ dbSNP | Ensembl ]. | VAR_059591 | |||||
| Natural variant | 209 | 1 | S → C. Corresponds to variant rs6940018 [ dbSNP | Ensembl ]. | VAR_050692 | |||||
| Natural variant | 459 | 1 | Y → D. Corresponds to variant rs1967446 [ dbSNP | Ensembl ]. | VAR_050693 | |||||
| Natural variant | 461 | 1 | L → H. Corresponds to variant rs1967445 [ dbSNP | Ensembl ]. | VAR_050694 | |||||
| Natural variant | 629 | 1 | N → S. Corresponds to variant rs7381749 [ dbSNP | Ensembl ]. | VAR_050695 | |||||
| Natural variant | 875 | 1 | R → C. Corresponds to variant rs34541670 [ dbSNP | Ensembl ]. | VAR_050696 | |||||
Experimental info | |||||||||
| Sequence conflict | 4 | 1 | S → A in AAF64304. Ref.1 | ||||||
Sequences
| ||||||||||||||||||||||||||||||||||||
References
| « Hide 'large scale' references | |
| [1] | "Btf, a novel death-promoting transcriptional repressor that interacts with Bcl-2-related proteins." Kasof G.M., Goyal L., White E. Mol. Cell. Biol. 19:4390-4404(1999) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 2 AND 3). |
| [2] | "Prediction of the coding sequences of unidentified human genes. V. The coding sequences of 40 new genes (KIAA0161-KIAA0200) deduced by analysis of cDNA clones from human cell line KG-1." Nagase T., Seki N., Ishikawa K., Tanaka A., Nomura N. DNA Res. 3:17-24(1996) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1). Tissue: Bone marrow. |
| [3] | "The DNA sequence and analysis of human chromosome 6." Mungall A.J., Palmer S.A., Sims S.K., Edwards C.A., Ashurst J.L., Wilming L., Jones M.C., Horton R., Hunt S.E., Scott C.E., Gilbert J.G.R., Clamp M.E., Bethel G., Milne S., Ainscough R., Almeida J.P., Ambrose K.D., Andrews T.D. Beck S.Nature 425:805-811(2003) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA] (ISOFORM 1). |
| [4] | Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S., Turner R. Venter J.C.Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. |
| [5] | "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)." The MGC Project Team Genome Res. 14:2121-2127(2004) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2), NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 1-676 (ISOFORM 4). Tissue: Brain, Pancreas, Testis and Uterus. |
| [6] | Bienvenut W.V., Heiserich L., Boulahbel H., Gottlieb E. Submitted (APR-2008) to UniProtKB Cited for: PROTEIN SEQUENCE OF 168-182; 189-204; 256-271; 284-298; 304-312; 319-332; 394-409; 422-439; 461-475; 505-517; 525-534; 537-548; 551-581; 587-593; 623-631; 654-664; 785-796; 832-842 AND 846-852, PHOSPHORYLATION AT SER-177; SER-268; SER-290; SER-512; SER-531 AND SER-658, MASS SPECTROMETRY. Tissue: Colon carcinoma. |
| [7] | "Emerin binding to Btf, a death-promoting transcriptional repressor, is disrupted by a missense mutation that causes Emery-Dreifuss muscular dystrophy." Haraguchi T., Holaska J.M., Yamane M., Koujin T., Hashiguchi N., Mori C., Wilson K.L., Hiraoka Y. Eur. J. Biochem. 271:1035-1045(2004) [PubMed] [Europe PMC] [Abstract] Cited for: INTERACTION WITH EMD. |
| [8] | "Global, in vivo, and site-specific phosphorylation dynamics in signaling networks." Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P., Mann M. Cell 127:635-648(2006) [PubMed] [Europe PMC] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-177; SER-389; SER-397; THR-402; SER-531 AND SER-648, MASS SPECTROMETRY. Tissue: Cervix carcinoma. |
| [9] | "Toward a global characterization of the phosphoproteome in prostate cancer cells: identification of phosphoproteins in the LNCaP cell line." Giorgianni F., Zhao Y., Desiderio D.M., Beranova-Giorgianni S. Electrophoresis 28:2027-2034(2007) [PubMed] [Europe PMC] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-397, MASS SPECTROMETRY. Tissue: Prostate cancer. |
| [10] | "Improved titanium dioxide enrichment of phosphopeptides from HeLa cells and high confident phosphopeptide identification by cross-validation of MS/MS and MS/MS/MS spectra." Yu L.-R., Zhu Z., Chan K.C., Issaq H.J., Dimitrov D.S., Veenstra T.D. J. Proteome Res. 6:4150-4162(2007) [PubMed] [Europe PMC] [Abstract] Cited for: IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. Tissue: Cervix carcinoma. |
| [11] | "Regulation of cyclin D1 RNA stability by SNIP1." Bracken C.P., Wall S.J., Barre B., Panov K.I., Ajuh P.M., Perkins N.D. Cancer Res. 68:7621-7628(2008) [PubMed] [Europe PMC] [Abstract] Cited for: FUNCTION, IDENTIFICATION IN THE SNARP COMPLEX. |
| [12] | "Phosphorylation analysis of primary human T lymphocytes using sequential IMAC and titanium oxide enrichment." Carrascal M., Ovelleiro D., Casas V., Gay M., Abian J. J. Proteome Res. 7:5167-5176(2008) [PubMed] [Europe PMC] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-397, MASS SPECTROMETRY. Tissue: T-cell. |
| [13] | "A quantitative atlas of mitotic phosphorylation." Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E., Elledge S.J., Gygi S.P. Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008) [PubMed] [Europe PMC] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-181; SER-222; SER-264; SER-268; TYR-284; SER-290; THR-341; SER-385; SER-389; SER-397; THR-402; SER-512; SER-531; SER-578 AND SER-658, MASS SPECTROMETRY. Tissue: Cervix carcinoma. |
| [14] | "Large-scale phosphoproteome analysis of human liver tissue by enrichment and fractionation of phosphopeptides with strong anion exchange chromatography." Han G., Ye M., Zhou H., Jiang X., Feng S., Jiang X., Tian R., Wan D., Zou H., Gu J. Proteomics 8:1346-1361(2008) [PubMed] [Europe PMC] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-177 AND SER-397, MASS SPECTROMETRY. Tissue: Liver. |
| [15] | "Quantitative phosphoproteomic analysis of T cell receptor signaling reveals system-wide modulation of protein-protein interactions." Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K., Rodionov V., Han D.K. Sci. Signal. 2:RA46-RA46(2009) [PubMed] [Europe PMC] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-177; SER-222; SER-290; SER-385; SER-397; THR-402 AND SER-512, MASS SPECTROMETRY. Tissue: Leukemic T-cell. |
| [16] | "Lysine acetylation targets protein complexes and co-regulates major cellular functions." Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.C., Olsen J.V., Mann M. Science 325:834-840(2009) [PubMed] [Europe PMC] [Abstract] Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-152; LYS-335 AND LYS-437, MASS SPECTROMETRY. |
| [17] | "Quantitative phosphoproteomics reveals widespread full phosphorylation site occupancy during mitosis." Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L., Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S., Mann M. Sci. Signal. 3:RA3-RA3(2010) [PubMed] [Europe PMC] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-102; SER-104; SER-177; SER-196; SER-198; SER-222; SER-268; SER-290; SER-297; SER-385; SER-397; THR-402; SER-472; SER-496; SER-502; SER-512; SER-531; THR-566; SER-578; SER-658 AND SER-690, MASS SPECTROMETRY. Tissue: Cervix carcinoma. |
| [18] | "Initial characterization of the human central proteome." Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J. BMC Syst. Biol. 5:17-17(2011) [PubMed] [Europe PMC] [Abstract] Cited for: IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. |
| [19] | "System-wide temporal characterization of the proteome and phosphoproteome of human embryonic stem cell differentiation." Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J., Johansen P.T., Kratchmarova I., Kassem M., Mann M., Olsen J.V., Blagoev B. Sci. Signal. 4:RS3-RS3(2011) [PubMed] [Europe PMC] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-177; SER-196; SER-198; SER-222; SER-268; SER-285; SER-290; SER-385; SER-397; THR-494; SER-496; SER-512; SER-531; SER-658; SER-660 AND SER-760, MASS SPECTROMETRY. |
| + | Additional computationally mapped references. |
Cross-references
Sequence databases | |
|---|---|
| EMBL GenBank DDBJ | AF249273 mRNA. Translation: AAF64304.1. D79986 mRNA. Translation: BAA11481.2. Different initiation. AL121713 Genomic DNA. Translation: CAB96722.1. CH471051 Genomic DNA. Translation: EAW47950.1. CH471051 Genomic DNA. Translation: EAW47951.1. BC047687 mRNA. Translation: AAH47687.1. Sequence problems. BC047887 mRNA. Translation: AAH47887.1. Sequence problems. BC056894 mRNA. Translation: AAH56894.1. Sequence problems. BC063846 mRNA. Translation: AAH63846.1. Sequence problems. BC132780 mRNA. Translation: AAI32781.1. BC144281 mRNA. Translation: AAI44282.1. |
| IPI | IPI00006079. IPI00413671. IPI00413672. IPI00413673. |
| RefSeq | NP_001070908.1. NM_001077440.1. NP_001070909.1. NM_001077441.1. NP_055554.1. NM_014739.2. |
| UniGene | Hs.486542. |
3D structure databases | |
| ProteinModelPortal | Q9NYF8. |
| ModBase | Search... |
Protein-protein interaction databases | |
| IntAct | Q9NYF8. 22 interactions. |
| MINT | MINT-92502. |
| STRING | 9606.ENSP00000031135. |
PTM databases | |
| PhosphoSite | Q9NYF8. |
Polymorphism databases | |
| DMDM | 47605556. |
Proteomic databases | |
| PaxDb | Q9NYF8. |
| PRIDE | Q9NYF8. |
Protocols and materials databases | |
| StructuralBiologyKnowledgebase | Search... |
Genome annotation databases | |
| Ensembl | ENST00000353331; ENSP00000229446; ENSG00000029363. ENST00000392348; ENSP00000376159; ENSG00000029363. ENST00000527759; ENSP00000434826; ENSG00000029363. ENST00000530767; ENSP00000436501; ENSG00000029363. ENST00000531224; ENSP00000435210; ENSG00000029363. |
| GeneID | 9774. |
| KEGG | hsa:9774. |
| UCSC | uc003qgw.1. human. uc003qgx.1. human. uc003qgy.1. human. uc011ede.1. human. |
Organism-specific databases | |
| CTD | 9774. |
| GeneCards | GC06M136621. |
| HGNC | HGNC:16863. BCLAF1. |
| HPA | HPA006669. HPA027770. |
| MIM | 612588. gene. |
| neXtProt | NX_Q9NYF8. |
| PharmGKB | PA134868035. |
| HUGE | Search... |
| GenAtlas | Search... |
Phylogenomic databases | |
| eggNOG | NOG88012. |
| HOVERGEN | HBG050681. |
| InParanoid | Q9NYF8. |
| KO | K13087. |
| OMA | HKSREQD. |
| OrthoDB | EOG4C2H94. |
| PhylomeDB | Q9NYF8. |
Gene expression databases | |
| ArrayExpress | Q9NYF8. |
| Bgee | Q9NYF8. |
| CleanEx | HS_BCLAF1. |
| Genevestigator | Q9NYF8. |
| GermOnline | ENSG00000029363. Homo sapiens. |
Family and domain databases | |
| InterPro | IPR026668. Bcl-2_assoc_TF1. [Graphical view] |
| PANTHER | PTHR15268:SF4. PTHR15268:SF4. 1 hit. |
| ProtoNet | Search... |
Other | |
| ChiTaRS | BCLAF1. human. |
| GenomeRNAi | 9774. |
| NextBio | 36794. |
| SOURCE | Search... |
Entry information
| Entry name | BCLF1_HUMAN | ||||||||
| Accession | Primary (citable) accession number: Q9NYF8 Secondary accession number(s): A2RU75 Q86WY0 | ||||||||
| Entry history |
| ||||||||
| Entry status | Reviewed (UniProtKB/Swiss-Prot) | ||||||||
| Annotation program | Chordata Protein Annotation Program | ||||||||
| Disclaimer | Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. It is not in any way intended to be used as a substitute for professional medical advice, diagnosis, treatment or care. | ||||||||
Relevant documents
| Human chromosome 6 Human chromosome 6: entries, gene names and cross-references to MIM |
| Human entries with polymorphisms or disease mutations List of human entries with polymorphisms or disease mutations |
| Human polymorphisms and disease mutations Index of human polymorphisms and disease mutations |
| MIM cross-references Online Mendelian Inheritance in Man (MIM) cross-references in UniProtKB/Swiss-Prot |

Clusters with
